As of, pregabalin and gabapentin are controlled under the Misuse of Drugs Act 2024 as Class C substances and scheduled under the Misuse of Drugs Regulations 2024 as Schedule 3.
As of, pregabalin and gabapentin are controlled under the Misuse of Drugs Act 2024 as Class C substances and scheduled under the Misuse of Drugs Regulations 2024 as Schedule 3.
Gabapentin is in a class of medications called anticonvulsants. Tennessee, and Virginia have reclassified gabapentin as a Schedule V controlled substance
As of, pregabalin and gabapentin are controlled under the Misuse of Drugs Act 2024 as Class C substances and scheduled under the Misuse of Drugs Regulations 2024 as Schedule 3.
As of, pregabalin and gabapentin are controlled under the Misuse of Drugs Act 2024 as Class C substances and scheduled under the Misuse of Drugs Regulations 2024 as Schedule 3.
As of, pregabalin and gabapentin are controlled under the Misuse of Drugs Act 2024 as Class C substances and scheduled under the Misuse of Drugs Regulations 2024 as Schedule 3.
scheduled under Schedule 3 (see Glossary for further information) OPTION 2 – Place pregabalin and gabapentin in class C of the 2024 Act and
Gabapentin Rescheduling The medication Gabapentin has been rescheduled as of today, 1st of April 2024. It is now classed as a Schedule 3 medication.
As of, pregabalin and gabapentin are controlled under the Misuse of Drugs Act 2024 as Class C substances and scheduled under the Misuse of Drugs Regulations 2024 as Schedule 3.
Comments